Recent advances in structure-based rational drug design

Current Opinion in Structural Biology

Volumn 10, Issue 4, 2000, Pages 401-404

  Gane, Paul J ^a   Dean, Philip M ^a  

^a De Novo Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; COMPLEX FORMATION; DRUG DESIGN; DRUG PROTEIN BINDING; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; DRUG DESIGN; HUMANS; PROTEIN ENGINEERING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033915982     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(00)00105-6     Document Type: Review

References (33)

1. Carlson H.A., McCammon J.A. Accommodating protein flexibility in computational drug design. Mol Pharmacol. 57:2000;213-218.
2. Carlson H.A., Masukawa K.M., McCammon J.A. Method for including the dynamic fluctuations of a protein in computer-aided drug design. J Phys Chem A. 103:1999;10 213-10 219.
3. Mangoni M., Roccatano D., Nola A.D. Docking of flexible ligands to flexible receptors in solution by molecular dynamics simulation. Proteins. 35:1999;153-162.
4. Kramer B., Rarey M., Lengauer T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins. 37:1999;228-241.
5. Murray C.W., Baxter C.A., Frenkel A.D. The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, thermolysin and neuraminidase. J Comput Aided Mol Des. 13:1999;547-562.
6. Knegtel R.M.A., Wagener M. Efficacy and selectivity in flexible database docking. Proteins. 37:1999;334-345.
7. Brem R., Dill K.A. The effect of multiple binding modes on empirical modeling of ligand docking to proteins. Protein Sci. 8:1999;1134-1143.
8. Rarey M., Kramer B., Lengauer T. The particle concept: placing discrete water molecules during protein-ligand docking predictions. Proteins. 34:1999;17-28.
9. Majeux N., Scarsi M., Apostolakis J., Ehrhardt C., Caflisch A. Exhaustive docking of molecular fragments with electrostatic solvation. Proteins. 37:1999;88-105.
10. Tame J.R.H. Scoring functions: a view from the bench. J Comput Aided Mol Des. 13:1999;99-108.
11. Gohlke H., Hendlich M., Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol. 295:2000;337-356.
12. Muegge I., Martin Y.C. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem. 42:1999;791-804.
13. Mitchell J.B.O., Laskowski R.A., Alex A., Thornton J.M. BLEEP - potential of mean force describing protein-ligand interactions: I. Generating potential. J Comput Chem. 20:1999;1165-1176.
14. Mitchell J.B.O., Laskowski R.A., Alex A., Forster M.J., Thornton J.M. BLEEP - potential of mean force describing protein-ligand interactions: 11. Calculation of binding energies and comparison with experimental data. J Comput Chem. 20:1999;1165-1176.
15. Liu M., Wang S. MCDOCK: a Monte Carlo simulation approach to the molecular docking problem. J Comput Aided Mol Des. 13:1999;435-451.
16. Trosset J.Y., Scheraga H.A. Prodock: software package for protein modeling and docking. J Comput Chem. 20:1999;412-427.
17. Makino S., Ewing T.J.A., Kuntz I.D. DREAM++: flexible docking program for virtual combinatorial libraries. J Comput Aided Mol Des. 13:1999;513-532.
18. Antel J. Integration of combinatorial chemistry and structure based drug design. Curr Opin Drug Discov Dev. 2:1999;224-233.
19. Davis A.M., Teague S.J. Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. Angew Chem Int Ed Engl. 38:1999;736-749.
20. Burkhard P., Hommel U., Sanner M., Walkinshaw M.D. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program. J Mol Biol. 287:1999;853-858.
21. DockCrunch on World Wide Web URL: http://www.protherics.com/crunch.
22. De Rienzo F., Fanelli F., Menziani M.C., De Benedetti P.G. Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4. J Comput Aided Mol Des. 14:2000;93-116.
23. Matthews D.A., Dragovich P.S., Webber S.E., Fuhrman S.A., Patick A.K., Zalman L.S., Hendrickson T.F., Love R.A., Prins T.J., Marakovits J.T.et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci USA. 96:1999;11 000-11 007.
24. Almstead N.G., Bradley R.S., Pikul S., De B., Natchus M.G., Taiwo Y.O., Gu F., Williams L.E., Hynd B.A., Janusz M.J.et al. Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors. J Med Chem. 42:1999;4547-4562.
25. Cheng M., De B., Almstead N.G., Pikul S.G., Dowty M.E., Dietsch C.R., Dunaway C.M., Gu F., Hsieh L.C., Janusz M.J.et al. Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold. J Med Chem. 42:1999;5426-5436.
26. Cheng M., De B., Pikul S., Almstead N.G., Natchus M.G., Anastasio M.V., McPhail S.J., Snider C.E., Taiwo Y.O., Chen L.et al. Design and synthesis of piperazine-based matrix metallo-proteinase inhibitors. J Med Chem. 43:2000;369-380.
27. Furet P., García-Echeverría C., Gay B., Schoepfer J., Zeller M., Rahuel J. Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic. J Med Chem. 42:1999;2358-2363.
28. 2 inhibitors, SPI. Biochim Biophys Acta. 1441:1999;223-228.
29. Aronov A.M., Suresh S., Buckner F.S., Van Voorhis W.C., Verlinde C.L.M.J., Opperdoes F.R., Hol W.G.J., Gelb M.H. Structure-based design of sub-micromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA. 96:1999;4273-4278.
30. Thaisrivongs S., Strohbach J.W. Structure-based discovery of tipranavir disodium (PNU-140690E): a potent, oral bio-available, non-peptidic HIV protease inhibitor. Biopolymers. 51:1999;51-58.
31. Willson T.M., Brown P.J., Sternbach D.D., Henke B.R. The PPARs: from orphan receptors to drug discovery. J Med Chem. 43:2000;527-550.
32. Moult J., Melamud E. From fold to function. Curr Opin Struct Biol. 10:2000;384-389.
33. Nienaber V., Wang J., Davidson D., Henkin J. Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite. J Biol Chem. 275:2000;7239-7248.